Good morning, For those of you who provide the service, what formulary option
has your institution adopted for the treatment of macular degeneration,
Avastin or Eylea? Could you share your protocol or policy for either?Thank you.
Sincerely,
Sudha
--
Sudha Narayanaswamy, PharmD, BCPP, BCGP
Senior Vice President,
Division of Pharmacy Practice
GNYHA Services, Inc. |
555 W. 57th Street, 11th Floor |
New York, NY 10019
o: 212-258-5376 | cell: 347-501-1770 l
f: 212-541-9032 |
E-mail: snarayanaswamy@xxxxxxxxx
Website: Http://pharmacy.gnyhaservices.com
